$9.70
0.000.00%
At close: -
$9.70
0.000.00%
After Hours: 4:00 PM EDT
Track the latest Rapport Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Rapport Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Rapport Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 8.50K shares worth $92.21K, meanwhile, insiders have reported buying a total of 16.00K shares for a total value of $162.24K.
Mar 17, 2025 | David Bredt | CHIEF SCIENTIFIC OFFICER | -8.50K | $10.85 | -$92.21K | SELL | -1.78% | 469.14K | Mar 14 | View |
Mar 13, 2025 | Troy Ignelzi | CHIEF FINANCIAL OFFICER | 10.00K | $10.10 | $100.99K | BUY | ∞ | 10.00K | Mar 12 - Mar 13 | View |
Mar 13, 2025 | Wendy Young | — | 6.00K | $10.21 | $61.25K | BUY | ∞ | 6.00K | Mar 12 | View |
Jul 03, 2024 | JAMES HEALY | DIRECTOR | 44.03K | $24.52 | $1.08M | BUY | 284.81% | 59.49K | Jul 01 | View |
Jun 10, 2024 | JAMES HEALY | — | 1.95M | $17.00 | $9.50M | BUY | ∞ | 25.45K | Jun 10 | View |
Browse insider trades on all stocks.